In a 5 to 1 vote today, the FDA Orthopaedic and Rehabilitation Devices advisory panel did not recommend approving Zimmer Spine’s premarket approval (PMA) application P070031 for marketing clearance of ...
Please provide your email address to receive an email when new articles are posted on . Patients who had a seizure prior to shoulder stabilization had a 29% recurrent instability rate. This was ...
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the launch of its R3ACT™ ...
Nashville, Tenn. (3:24 p.m. EDT--July 10, 2021)--Approximately 12 percent of patients who underwent shoulder stabilization surgery experience arthritis in the shoulder joint within a seven-year period ...
IlluminOss Medical, a privately held, commercial stage medical device company pioneering the development of minimally invasive fracture fixation technologies, announced that it has received a Notice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback